PI
ITOS

Putnam Investments’s iTeos Therapeutics ITOS Stock Holding History

Putnam Investments’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$382K Buy
+34,904
New +$346K ﹤0.01% 1028
2022
Q3 		– Sell
-36,202
Closed -$745K – 1176
2022
Q2 		$745K Sell
36,202
-3,163
-8% -$75.1K ﹤0.01% 899
2022
Q1 		$1.27M Sell
39,365
-2,944
-7% -$107K ﹤0.01% 877
2021
Q4 		$1.97M Buy
+42,309
New +$1.41M ﹤0.01% 764

Other funds holding ITOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Putnam Investments's ITOS Position: Q4 2023 in Review

Putnam Investments opened a new position in iTeos Therapeutics (ITOS) in Q4 2023: 34,904 shares worth $382K. The stake represents ﹤0.01% of the portfolio and ranks #1028 among its holdings. This is a return to the name: Putnam Investments previously reported a position in ITOS as recently as Q2 2022.

Putnam Investments first reported a position in ITOS in Q4 2021 and has held it in 4 quarters since. The position peaked at $1.97M in Q4 2021. 138 funds tracked by Wall St. Rank hold ITOS as of Q4 2023.

  • Putnam Investments held 34,904 shares of iTeos Therapeutics worth $382K as of Q4 2023.
  • iTeos Therapeutics was a new Putnam Investments position in Q4 2023.
  • iTeos Therapeutics made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #1028 holding.
  • Putnam Investments first reported a position in iTeos Therapeutics in Q4 2021 and has held it in 4 quarters since.
  • Putnam Investments's iTeos Therapeutics position peaked at $1.97M in Q4 2021.
  • 138 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.